Together, these results indicate that PIK3CA mutation mediates resistance to EGFR inhibition via the sustained activation of EGFR/PI3K signaling in the presence of TKI in HNSCC cells. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.